Recognition List Number: 028 Publication Date: 03/16/2012
Part B: SUPPLEMENTARY INFORMATION
Recognition Number 17-7: ISO 7197:2006 Technical Corrigendum1:2007, Neurological implants - Sterile, single-use hydrocephalus shunts and components. (Neurology)
Date of Standard: 2006. |
| Address of Standards Organization: |
| International Organization for Standardization (ISO)* |
| 1, Rue de Varembe |
| Case Postale 56 |
| CH 1211 Geneva 20, 0 |
|
SWITZERLAND
|
|
| CDRH Office and Division Associated with Recognized Standards: |
| OFFICE OF DEVICE EVALUATION (ODE) | | |
|
|
| Devices Affected: |
Sterile, single use hydrocephalus shunts and components including:
a. one piece type
b. multiple types either assembled or in kit form
c. individual shunt components or in combination |
|
| Processes Affected: |
| 510(k), IDE, PMA, PDP, HDE |
|
| Type of Standard: |
| Vertical, International, Test Methods |
| Extent of Recognition: |
| Complete Technical Corrigendum 1 |
|
| Related CFR Citations and Product Codes: |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §882.4060 |
Cannula, Ventricular |
Class 1 |
HCD |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §882.4100 |
Catheter, Ventricular |
Class 2 |
HCA |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §882.4545 |
Instrument, Shunt System Implantation |
Class 1 |
GYK |
| |
Regulation Number |
Device Name |
Device Class |
Product Code |
| §882.5550 |
Shunt, Central Nervous System And Components |
Class 2 |
JXG |
| |
|
| Relevant Guidance: |
Required Biocompatibility Training and Toxicology Profiles for Evaluation of Medical Devices; May 1, 1995 (G95-1)
Guideline on Validation of the LAL Test as an End-Product Endotoxin Test for Human and Animal Parental Drugs, Biological Products, and Medical Devices. Document issued prior to February 1997. |
|
| FDA Technical Contact: |
| Joseph C. Hutter |
| FDA/CDRH/ODE |
| 10903 New Hampshire Avenue Building 66, Room 2458 |
| Silver Spring MD 20993 |
| 301/796-6499 |
| Email: joseph.hutter@fda.hhs.gov |
|
|